![Cheryl Maley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cheryl Maley
Vorstandsvorsitzender bei
STARPHARMA HOLDINGS LIMITED
Vermögen: 62 225 $ am 30.06.2026
Profil
Cheryl Maley is currently the Chief Executive Officer, Director & MD at Starpharma Holdings Ltd. She previously held positions as the Chief Executive Officer at Biointelect Pty Ltd., Independent Non-Executive Director at Medlab Clinical Ltd., Non-Executive Director at Clarity Pharmaceuticals Ltd., Managing Director-Oncology at Novartis Australia Pty Ltd. and Novartis New Zealand Ltd., Director-Commercial Excellence at AbbVie Pty Ltd., and President & Country Head at Novartis Pharma (Philippines).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.12.2025 | 128’309 ( 0.03% ) | 62 225 $ | 30.06.2026 |
Aktive Positionen von Cheryl Maley
| Unternehmen | Position | Beginn |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Vorstandsvorsitzender | 08.01.2024 |
Ehemalige bekannte Positionen von Cheryl Maley
| Unternehmen | Position | Ende |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Direktor/Vorstandsmitglied | 16.01.2024 |
Biointelect Pty Ltd.
 Biointelect Pty Ltd. Investment ManagersFinance Provides clinical, regulatory, market evaluation reimbursement strategies and partnering advices | Vorstandsvorsitzender | 01.12.2023 |
| MEDB CLIN | Direktor/Vorstandsmitglied | 26.02.2023 |
Novartis Australia Pty Ltd.
 Novartis Australia Pty Ltd. BiotechnologyHealth Technology Manufactures biological products | Corporate Officer/Principal | 01.10.2022 |
Novartis New Zealand Ltd.
 Novartis New Zealand Ltd. Medical DistributorsDistribution Services Markets pharmaceutical products | Corporate Officer/Principal | 01.10.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
21
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Starpharma Holdings Ltd.
 Starpharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dendrimer products for pharmaceutical, life science & other applications | Health Technology |
Novartis Australia Pty Ltd.
Novartis Australia Pty Ltd. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
Novartis New Zealand Ltd.
Novartis New Zealand Ltd. Medical DistributorsDistribution Services Markets pharmaceutical products | Distribution Services |
AbbVie Pty Ltd.
 AbbVie Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Medlab Clinical Ltd.
 Medlab Clinical Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug development | Health Technology |
Biointelect Pty Ltd.
Biointelect Pty Ltd. Investment ManagersFinance Provides clinical, regulatory, market evaluation reimbursement strategies and partnering advices | Finance |
Clarity Pharmaceuticals Ltd.
 Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Novartis Pharma (Philippines) |
